Top
United States Biosimilar Drug Industry 2016 Deep Market Research Report
Category : Pharmaceuticals  | Published Date : Jun-2016 | Pages : 131
enquire GET DISCOUNT
The report

United States Biosimilar Drug Industry

2016 Deep Market Research Report offers comprehensive insights into current market dynamics and emerging industry trends, product definition and main specifications, key manufacturing technology, detailed profiles of major market players along with detailed segmentation and forecasts. An in-depth status of key market dynamics, restraining factors, and industry challenges are offered in the analysis; the factors responsible for the change in competitive landscape scenario and the winning strategies adopted by market players are considered in the report. The study offer detailed quantitative analysis by covering market revenue shares of prominent companies, production share and data, import-export trends and growth prospects of segments in major regions along the forecast period.

The study provides market participants and stakeholders an incisive analysis of the prominent strategies of companies and manufacturers across the globe. The analysis tracks the industry chain and various factors that impact its development. The analysis is useful to investors and stakeholders to gain an insight into crucial factors that affect key market dynamics along with the measures undertaken by top buyers and sellers to add value across industry chain. Recent policy changes, regulatory framework, technological advancements in United States Biosimilar Drug Industry are considered in detail in the report. The study offers the different market channels adopted by top vendors the strategies adopted by them to consolidate their market share. Furthermore, quantitative analysis includes recent data and statistics on the production and consumption of the various product offerings in the industry. The analysis covers a reliable estimate of various parameters such as cost & profit, supply & demand, and ROI of the major stakeholders.

The study offers a detailed feasibility analysis of marketing channels and the projects associated with them; this will expand the understanding the market status and favorable factors for new entrants. In addition, critical assessment of recent product launches, technological innovations and R&D activities by stakeholders help the market participants to get a strategic analysis of business environment in various regions. The analysis offers data on the funding of major projects on United States Biosimilar Drug Industry, which will help the market players to know the imminent investment pockets.
Table of Contents

1 Industry Overview
1.1 Definition and Specifications of Biosimilar Drug
1.1.1 Definition of Biosimilar Drug
1.1.2 Specifications of Biosimilar Drug
1.2 Classification of Biosimilar Drug
1.3 Applications of Biosimilar Drug
1.4 Industry Chain Structure of Biosimilar Drug
1.5 Industry Overview of Biosimilar Drug
1.6 Industry Policy Analysis of Biosimilar Drug
1.7 Industry News Analysis of Biosimilar Drug

2 Manufacturing Cost Structure Analysis of Biosimilar Drug
2.1 Bill of Materials (BOM) of Biosimilar Drug
2.2 BOM Price Analysis of Biosimilar Drug
2.3 Labor Cost Analysis of Biosimilar Drug
2.4 Depreciation Cost Analysis of Biosimilar Drug
2.5 Manufacturing Cost Structure Analysis of Biosimilar Drug
2.6 Manufacturing Process Analysis of Biosimilar Drug
2.7 United States Price, Cost and Gross of Biosimilar Drug 2011-2016

3 Technical Data and Manufacturing Plants Analysis
3.1 Capacity and Commercial Production Date of United States Key Manufacturers in 2015
3.2 Manufacturing Plants Distribution of United States Key Biosimilar Drug Manufacturers in 2015
3.3 R&D Status and Technology Source of United States Biosimilar Drug Key Manufacturers in 2015
3.4 Raw Materials Sources Analysis of United States Biosimilar Drug Key Manufacturers in 2015

4 Production Analysis of Biosimilar Drug by Regions, Type, and Applications
4.1 United States Production of Biosimilar Drug by Regions 2011-2016
4.2 United States Production of Biosimilar Drug by Type 2011-2016
4.3 United States Sales of Biosimilar Drug by Applications 2011-2016
4.4 Price Analysis of United States Biosimilar Drug Key Manufacturers in 2015
4.5 United States Capacity, Production, Import, Export, Sales, Price, Cost and Revenue of Biosimilar Drug 2011-2016

5 Consumption Volume and Consumption Value Analysis of Biosimilar Drug by Regions
5.1 United States Consumption Volume of Biosimilar Drug by Regions 2011-2016
5.2 United States Consumption Value of Biosimilar Drug by Regions 2011-2016
5.3 United States Consumption Price Analysis of Biosimilar Drug by Regions 2011-2016

6 Analysis of Biosimilar Drug Production, Supply, Sales and Market Status 2011-2016
6.1 Capacity, Production, Sales, and Revenue of Biosimilar Drug 2011-2016
6.2 Production Market Share and Sales Market Share Analysis of Biosimilar Drug 2014-2015
6.3 Sales Overview of Biosimilar Drug 2011-2016
6.4 Supply, Consumption and Gap of Biosimilar Drug 2011-2016
6.5 Import, Export and Consumption of Biosimilar Drug 2011-2016
6.6 Cost, Price, Revenue and Gross Margin of Biosimilar Drug 2011-2016

7 Analysis of Biosimilar Drug Industry Key Manufacturers
7.1 Hospira
7.1.1 Company Profile
7.1.2 Product Picture and Specifications
7.1.2.1 Type I
7.1.2.2 Type II
7.1.2.3 Type III
7.1.3 Capacity, Production, Price, Cost, Gross and Revenue
7.1.4 Contact Information

7.2 Sandoz
7.2.1 Company Profile
7.2.2 Product Picture and Specifications
7.2.2.1 Type I
7.2.2.2 Type II
7.2.2.3 Type III
7.2.3 Capacity, Production, Price, Cost, Gross and Revenue
7.2.4 Contact Information

7.3 Teva Pharmaceutical Industries
7.3.1 Company Profile
7.3.2 Product Picture and Specifications
7.3.2.1 Type I
7.3.2.2 Type II
7.3.2.3 Type III
7.3.3 Capacity, Production, Price, Cost, Gross and Revenue
7.3.4 Contact Information

7.4 Pfizer
7.4.1 Company Profile
7.4.2 Product Picture and Specifications
7.4.2.1 Type I
7.4.2.2 Type II
7.4.2.3 Type III
7.4.3 Capacity, Production, Price, Cost, Gross and Revenue
7.4.4 Contact Information

7.5 Merck Sharp & Dohme
7.5.1 Company Profile
7.5.2 Product Picture and Specifications
7.5.2.1 Type I
7.5.2.2 Type II
7.5.2.3 Type III
7.5.3 Capacity, Production, Price, Cost, Gross and Revenue
7.5.4 Contact Information

7.6 Celltrion
7.6.1 Company Profile
7.6.2 Product Picture and Specifications
7.6.2.1 Type I
7.6.2.2 Type II
7.6.2.3 Type III
7.6.3 Capacity, Production, Price, Cost, Gross and Revenue
7.6.4 Contact Information

7.7 Amgen
7.7.1 Company Profile
7.7.2 Product Picture and Specifications
7.7.2.1 Type I
7.7.2.2 Type II
7.7.2.3 Type III
7.7.3 Capacity, Production, Price, Cost, Gross and Revenue
7.7.4 Contact Information

7.8 Biogen
7.8.1 Company Profile
7.8.2 Product Picture and Specifications
7.8.2.1 Type I
7.8.2.2 Type II
7.8.2.3 Type III
7.8.3 Capacity, Production, Price, Cost, Gross and Revenue
7.8.4 Contact Information

7.9 Mylan
7.9.1 Company Profile
7.9.2 Product Picture and Specifications
7.9.2.1 Type I
7.9.2.2 Type II
7.9.2.3 Type III
7.9.3 Capacity, Production, Price, Cost, Gross and Revenue
7.9.4 Contact Information

7.10 Biocon
7.10.1 Company Profile
7.10.2 Product Picture and Specifications
7.10.2.1 Type I
7.10.2.2 Type II
7.10.2.3 Type III
7.10.3 Capacity, Production, Price, Cost, Gross and Revenue
7.10.4 Contact Information

7.11 Dr. Reddy’s Laboratories
7.11.1 Company Profile
7.11.2 Product Picture and Specifications
7.11.2.1 Type I
7.11.2.2 Type II
7.11.2.3 Type III
7.11.3 Capacity, Production, Price, Cost, Gross and Revenue
7.11.4 Contact Information

7.12 Boehringer Ingelheim GmbH
7.12.1 Company Profile
7.12.2 Product Picture and Specifications
7.12.2.1 Type I
7.12.2.2 Type II
7.12.2.3 Type III
7.12.3 Capacity, Production, Price, Cost, Gross and Revenue
7.12.4 Contact Information

7.13 Intas Pharmaceuticals
7.13.1 Company Profile
7.13.2 Product Picture and Specifications
7.13.2.1 Type I
7.13.2.2 Type II
7.13.2.3 Type III
7.13.3 Capacity, Production, Price, Cost, Gross and Revenue
7.13.4 Contact Information

7.14 LG Life Sciences
7.14.1 Company Profile
7.14.2 Product Picture and Specifications
7.14.2.1 Type I
7.14.2.2 Type II
7.14.2.3 Type III
7.14.3 Capacity, Production, Price, Cost, Gross and Revenue
7.14.4 Contact Information

7.15 Emcure Pharmaceuticals
7.15.1 Company Profile
7.15.2 Product Picture and Specifications
7.15.2.1 Type I
7.15.2.2 Type II
7.15.2.3 Type III
7.15.3 Capacity, Production, Price, Cost, Gross and Revenue
7.15.4 Contact Information

7.16 Probiomed
7.16.1 Company Profile
7.16.2 Product Picture and Specifications
7.16.2.1 Type I
7.16.2.2 Type II
7.16.2.3 Type III
7.16.3 Capacity, Production, Price, Cost, Gross and Revenue
7.16.4 Contact Information

7.17 Biosidus
7.17.1 Company Profile
7.17.2 Product Picture and Specifications
7.17.2.1 Type I
7.17.2.2 Type II
7.17.2.3 Type III
7.17.3 Capacity, Production, Price, Cost, Gross and Revenue
7.17.4 Contact Information

7.18 3SBio
7.18.1 Company Profile
7.18.2 Product Picture and Specifications
7.18.2.1 Type I
7.18.2.2 Type II
7.18.2.3 Type III
7.18.3 Capacity, Production, Price, Cost, Gross and Revenue
7.18.4 Contact Information

7.19 WOCKHARDT
7.19.1 Company Profile
7.19.2 Product Picture and Specifications
7.19.2.1 Type I
7.19.2.2 Type II
7.19.2.3 Type III
7.19.3 Capacity, Production, Price, Cost, Gross and Revenue
7.19.4 Contact Information

7.20 Sun Pharmaceutical Industries
7.20.1 Company Profile
7.20.2 Product Picture and Specifications
7.20.2.1 Type I
7.20.2.2 Type II
7.20.2.3 Type III
7.20.3 Capacity, Production, Price, Cost, Gross and Revenue
7.20.4 Contact Information

7.21 Shanghai Fosun Pharmaceutical
7.21.1 Company Profile
7.21.2 Product Picture and Specifications
7.21.2.1 Type I
7.21.2.2 Type II
7.21.2.3 Type III
7.21.3 Capacity, Production, Price, Cost, Gross and Revenue
7.21.4 Contact Information

7.22 Qilu Pharmaceutical
7.22.1 Company Profile
7.22.2 Product Picture and Specifications
7.22.2.1 Type I
7.22.2.2 Type II
7.22.2.3 Type III
7.22.3 Capacity, Production, Price, Cost, Gross and Revenue
7.22.4 Contact Information

7.23 Allergan
7.23.1 Company Profile
7.23.2 Product Picture and Specifications
7.23.2.1 Type I
7.23.2.2 Type II
7.23.2.3 Type III
7.23.3 Capacity, Production, Price, Cost, Gross and Revenue
7.23.4 Contact Information

7.24 Dongbao
7.24.1 Company Profile
7.24.2 Product Picture and Specifications
7.24.2.1 Type I
7.24.2.2 Type II
7.24.2.3 Type III
7.24.3 Capacity, Production, Price, Cost, Gross and Revenue
7.24.4 Contact Information

7.25 Samsung Biologics
7.25.1 Company Profile
7.25.2 Product Picture and Specifications
7.25.2.1 Type I
7.25.2.2 Type II
7.25.2.3 Type III
7.25.3 Capacity, Production, Price, Cost, Gross and Revenue
7.25.4 Contact Information

7.26 Zydus Cadila.
7.26.1 Company Profile
7.26.2 Product Picture and Specifications
7.26.2.1 Type I
7.26.2.2 Type II
7.26.2.3 Type III
7.26.3 Capacity, Production, Price, Cost, Gross and Revenue
7.26.4 Contact Information

7.27 Dong-A Pharmaceutical
7.27.1 Company Profile
7.27.2 Product Picture and Specifications
7.27.2.1 Type I
7.27.2.2 Type II
7.27.2.3 Type III
7.27.3 Capacity, Production, Price, Cost, Gross and Revenue
7.27.4 Contact Information

8 Price and Gross Margin Analysis
8.1 Analysis of Price
8.2 Gross Margin Analysis
8.3 Price Comparison by Regions
8.4 Price Analysis of Different Biosimilar Drug Product Types
8.5 Market Share Analysis of Different Biosimilar Drug Price Levels
8.6 Gross Margin Analysis of Different Biosimilar Drug Applications

9 Marketing Trader or Distributor Analysis of Biosimilar Drug
9.1 Marketing Channels Status of Biosimilar Drug
9.2 Traders or Distributors of Biosimilar Drug with Contact Information
9.3 Ex-work Price, Channel Price and End Buyer Price Analysis of Biosimilar Drug
9.4 United States Import, Export and Trade Analysis of Biosimilar Drug

10 Development Trend of Biosimilar Drug Industry 2016-2021
10.1 Capacity and Production Overview of Biosimilar Drug 2016-2021
10.2 Production Market Share by Product Types of Biosimilar Drug 2016-2021
10.3 Sales and Sales Revenue Overview of Biosimilar Drug 2016-2021
10.4 United States Sales of Biosimilar Drug by Applications 2016-2021
10.5 Import, Export and Consumption of Biosimilar Drug 2016-2021
10.6 Cost, Price, Revenue and Gross Margin of Biosimilar Drug 2016-2021

11 Industry Chain Suppliers of Biosimilar Drug with Contact Information
11.1 Major Raw Materials Suppliers of Biosimilar Drug with Contact Information
11.2 Manufacturing Equipment Suppliers of Biosimilar Drug with Contact Information
11.3 Major Players of Biosimilar Drug with Contact Information
11.4 Key Consumers of Biosimilar Drug with Contact Information
11.5 Supply Chain Relationship Analysis of Biosimilar Drug

12 New Project Investment Feasibility Analysis of Biosimilar Drug
12.1 New Project SWOT Analysis of Biosimilar Drug
12.2 New Project Investment Feasibility Analysis of Biosimilar Drug

13 Conclusion of the United States Biosimilar Drug Industry 2016 Market Research Report


List Of Tables and Figures

Figure Picture of Biosimilar Drug
Table Product Specifications of Biosimilar Drug
Table Classification of Biosimilar Drug
Figure United States Sales Market Share of Biosimilar Drug by Product Types in 2015
Table Applications of Biosimilar Drug
Figure United States Sales Market Share of Biosimilar Drug by Applications in 2015
Figure Industry Chain Structure of Biosimilar Drug
Table United States Industry Overview of Biosimilar Drug
Table Industry Policy of Biosimilar Drug
Table Industry News List of Biosimilar Drug
Table Bill of Materials (BOM) of Biosimilar Drug
Table Bill of Materials (BOM) Price of Biosimilar Drug
Table Labor Cost of Biosimilar Drug
Table Depreciation Cost of Biosimilar Drug
Table Manufacturing Cost Structure Analysis of Biosimilar Drug in 2015
Figure Manufacturing Process Analysis of Biosimilar Drug
Table United States Price Analysis of Biosimilar Drug 2011-2016 (USD/Dose)
Table United States Cost Analysis of Biosimilar Drug 2011-2016 (USD/Dose)
Table United States Gross Analysis of Biosimilar Drug 2011-2016
Table Capacity (K Dose) and Commercial Production Date of United States Biosimilar Drug Key Manufacturers in 2015
Table Manufacturing Plants Distribution of United States Key Biosimilar Drug Manufacturers in 2015
Table R&D Status and Technology Source of United States Biosimilar Drug Key Manufacturers in 2015
Table Raw Materials Sources Analysis of United States and United States Biosimilar Drug Key Manufacturers in 2015
Table United States Production of Biosimilar Drug by Regions 2011-2016 (K Dose)
Table United States Production Market Share of Biosimilar Drug by Regions 2011-2016
Figure United States Production Market Share of Biosimilar Drug by Regions in 2014
Figure United States Production Market Share of Biosimilar Drug by Regions in 2015
Table United States Production of Biosimilar Drug by Types in 2011-2016 (K Dose)
Table United States Production Market Share of Biosimilar Drug by Type in 2011-2016
Figure United States Production Market Share of Biosimilar Drug by Type in 2014
Figure United States Production Market Share of Biosimilar Drug by Type in 2015
Table United States Sales of Biosimilar Drug by Applications 2011-2016 (K Dose)
Table United States Production Market Share of Biosimilar Drug by Applications 2011-2016
Figure United States Production Market Share of Biosimilar Drug by Applications in 2014
Figure United States Production Market Share of Biosimilar Drug by Applications in 2015
Table Price Comparison of United States Biosimilar Drug Key Manufacturers in 2015 (USD/Dose)
Table United States Capacity, Production, Import Export Sales Price , Cost and Revenue (M USD) of Biosimilar Drug 2011-2016
Table United States Consumption Volume of Biosimilar Drug by Regions 2011-2016 (K Dose)
Table United States Consumption Volume Market Share of Biosimilar Drug by Regions 2011-2016
Figure United States Consumption Volume Market Share of Biosimilar Drug by Regions in 2014
Figure United States Consumption Volume Market Share of Biosimilar Drug by Regions in 2015
Table United States Consumption Value of Biosimilar Drug by Regions 2011-2016 (M USD)
Table United States Consumption Value Market Share of Biosimilar Drug by Regions 2011-2016
Figure United States Consumption Value Market Share of Biosimilar Drug by Regions in 2014
Figure United States Consumption Value Market Share of Biosimilar Drug by Regions in 2015
Table Consumption Price of Biosimilar Drug by Regions 2011-2016 (USD/Dose)
Table United States and Major Manufacturers Capacity of Biosimilar Drug 2011-2016 (K Dose)
Table United States Capacity Market Share of Major Biosimilar Drug Manufacturers 2011-2016
Table United States and Major Manufacturers Production of Biosimilar Drug 2011-2016 (K Dose)
Table United States Production Market Share of Major Biosimilar Drug Manufacturers 2011-2016
Table United States and Major Manufacturers Sales of Biosimilar Drug 2011-2016 (K Dose)
Table United States Sales Market Share of Major Biosimilar Drug Manufacturers 2011-2016
Table United States and Major Manufacturers Sales Revenue of Biosimilar Drug 2011-2016 (M USD)
Table United States Sales Revenue Market Share of Major Biosimilar Drug Manufacturers 2011-2016
Figure United States Capacity (K Dose), Production (K Dose) and Growth Rate of Biosimilar Drug 2011-2016
Figure United States Capacity Utilization Rate of Biosimilar Drug 2011-2016
Figure United States Sales Revenue (M USD) and Growth Rate of Biosimilar Drug 2011-2016
Figure United States Production Market Share of Major Biosimilar Drug Manufacturers in 2014
Figure United States Production Market Share of Major Biosimilar Drug Manufacturers in 2015
Figure United States Sales Market Share of Major Biosimilar Drug Manufacturers in 2014
Figure United States Sales Market Share of Major Biosimilar Drug Manufacturers in 2015
Figure United States Sales (K Dose) and Growth Rate of Biosimilar Drug 2011-2016
Table United States Supply, Consumption and Gap of Biosimilar Drug 2011-2016 (K Dose)
Table United States Import, Export and Consumption of Biosimilar Drug 2011-2016 (K Dose)
Table Price of United States Biosimilar Drug Major Manufacturers 2011-2016 (USD/Dose)
Table Gross Margin of United States Biosimilar Drug Major Manufacturers 2011-2016
Table United States and Major Manufacturers Revenue of Biosimilar Drug 2011-2016 (M USD)
Table United States Capacity (K Dose), Production (K Dose), Price (USD/Dose), Cost (USD/Dose), Revenue (M USD) and Gross Margin of Biosimilar Drug 2011-2016
Table Hospira Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Biosimilar Drug Picture and Specifications of Hospira
Table Biosimilar Drug Capacity (K Dose), Production (K Dose), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Hospira 2011-2016
Figure Biosimilar Drug Capacity (K Dose), Production (K Dose) and Growth Rate of Hospira 2011-2016
Figure Biosimilar Drug Production (K Dose) and United States Market Share of Hospira 2011-2016
Table Hospira Biosimilar Drug SWOT Analysis
Table Sandoz Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Biosimilar Drug Picture and Specifications of Sandoz
Table Biosimilar Drug Capacity (K Dose), Production (K Dose), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Sandoz 2011-2016
Figure Biosimilar Drug Capacity (K Dose), Production (K Dose) and Growth Rate of Sandoz 2011-2016
Figure Biosimilar Drug Production (K Dose) and United States Market Share of Sandoz 2011-2016
Table Sandoz Biosimilar Drug SWOT Analysis
Table Teva Pharmaceutical Industries Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Biosimilar Drug Picture and Specifications of Teva Pharmaceutical Industries
Table Biosimilar Drug Capacity (K Dose), Production (K Dose), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Teva Pharmaceutical Industries 2011-2016
Figure Biosimilar Drug Capacity (K Dose), Production (K Dose) and Growth Rate of Teva Pharmaceutical Industries 2011-2016
Figure Biosimilar Drug Production (K Dose) and United States Market Share of Teva Pharmaceutical Industries 2011-2016
Table Teva Pharmaceutical Industries Biosimilar Drug SWOT Analysis
Table Pfizer Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Biosimilar Drug Picture and Specifications of Pfizer
Table Biosimilar Drug Capacity (K Dose), Production (K Dose), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Pfizer 2011-2016
Figure Biosimilar Drug Capacity (K Dose), Production (K Dose) and Growth Rate of Pfizer 2011-2016
Figure Biosimilar Drug Production (K Dose) and United States Market Share of Pfizer 2011-2016
Table Pfizer Biosimilar Drug SWOT Analysis
Table Merck Sharp & Dohme Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Biosimilar Drug Picture and Specifications of Merck Sharp & Dohme
Table Biosimilar Drug Capacity (K Dose), Production (K Dose), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Merck Sharp & Dohme 2011-2016
Figure Biosimilar Drug Capacity (K Dose), Production (K Dose) and Growth Rate of Merck Sharp & Dohme 2011-2016
Figure Biosimilar Drug Production (K Dose) and United States Market Share of Merck Sharp & Dohme 2011-2016
Table Merck Sharp & Dohme Biosimilar Drug SWOT Analysis
Table Celltrion Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Biosimilar Drug Picture and Specifications of Celltrion
Table Biosimilar Drug Capacity (K Dose), Production (K Dose), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Celltrion 2011-2016
Figure Biosimilar Drug Capacity (K Dose), Production (K Dose) and Growth Rate of Celltrion 2011-2016
Figure Biosimilar Drug Production (K Dose) and United States Market Share of Celltrion 2011-2016
Table Celltrion Biosimilar Drug SWOT Analysis
Table Amgen Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Biosimilar Drug Picture and Specifications of Amgen
Table Biosimilar Drug Capacity (K Dose), Production (K Dose), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Amgen 2011-2016
Figure Biosimilar Drug Capacity (K Dose), Production (K Dose) and Growth Rate of Amgen 2011-2016
Figure Biosimilar Drug Production (K Dose) and United States Market Share of Amgen 2011-2016
Table Amgen Biosimilar Drug SWOT Analysis
Table Biogen Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Biosimilar Drug Picture and Specifications of Biogen
Table Biosimilar Drug Capacity (K Dose), Production (K Dose), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Biogen 2011-2016
Figure Biosimilar Drug Capacity (K Dose), Production (K Dose) and Growth Rate of Biogen 2011-2016
Figure Biosimilar Drug Production (K Dose) and United States Market Share of Biogen 2011-2016
Table Biogen Biosimilar Drug SWOT Analysis
Table Mylan Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Biosimilar Drug Picture and Specifications of Mylan
Table Biosimilar Drug Capacity (K Dose), Production (K Dose), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Mylan 2011-2016
Figure Biosimilar Drug Capacity (K Dose), Production (K Dose) and Growth Rate of Mylan 2011-2016
Figure Biosimilar Drug Production (K Dose) and United States Market Share of Mylan 2011-2016
Table Mylan Biosimilar Drug SWOT Analysis
Table Biocon Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Biosimilar Drug Picture and Specifications of Biocon
Table Biosimilar Drug Capacity (K Dose), Production (K Dose), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Biocon 2011-2016
Figure Biosimilar Drug Capacity (K Dose), Production (K Dose) and Growth Rate of Biocon 2011-2016
Figure Biosimilar Drug Production (K Dose) and United States Market Share of Biocon 2011-2016
Table Biocon Biosimilar Drug SWOT Analysis
Table Dr. Reddy’s Laboratories Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Biosimilar Drug Picture and Specifications of Dr. Reddy’s Laboratories
Table Biosimilar Drug Capacity (K Dose), Production (K Dose), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Dr. Reddy’s Laboratories 2011-2016
Figure Biosimilar Drug Capacity (K Dose), Production (K Dose) and Growth Rate of Dr. Reddy’s Laboratories 2011-2016
Figure Biosimilar Drug Production (K Dose) and United States Market Share of Dr. Reddy’s Laboratories 2011-2016
Table Dr. Reddy’s Laboratories Biosimilar Drug SWOT Analysis
Table Boehringer Ingelheim GmbH Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Biosimilar Drug Picture and Specifications of Boehringer Ingelheim GmbH
Table Biosimilar Drug Capacity (K Dose), Production (K Dose), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Boehringer Ingelheim GmbH 2011-2016
Figure Biosimilar Drug Capacity (K Dose), Production (K Dose) and Growth Rate of Boehringer Ingelheim GmbH 2011-2016
Figure Biosimilar Drug Production (K Dose) and United States Market Share of Boehringer Ingelheim GmbH 2011-2016
Table Boehringer Ingelheim GmbH Biosimilar Drug SWOT Analysis
Table Intas Pharmaceuticals Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Biosimilar Drug Picture and Specifications of Intas Pharmaceuticals
Table Biosimilar Drug Capacity (K Dose), Production (K Dose), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Intas Pharmaceuticals 2011-2016
Figure Biosimilar Drug Capacity (K Dose), Production (K Dose) and Growth Rate of Intas Pharmaceuticals 2011-2016
Figure Biosimilar Drug Production (K Dose) and United States Market Share of Intas Pharmaceuticals 2011-2016
Table Intas Pharmaceuticals Biosimilar Drug SWOT Analysis
Table LG Life Sciences Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Biosimilar Drug Picture and Specifications of LG Life Sciences
Table Biosimilar Drug Capacity (K Dose), Production (K Dose), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of LG Life Sciences 2011-2016
Figure Biosimilar Drug Capacity (K Dose), Production (K Dose) and Growth Rate of LG Life Sciences 2011-2016
Figure Biosimilar Drug Production (K Dose) and United States Market Share of LG Life Sciences 2011-2016
Table LG Life Sciences Biosimilar Drug SWOT Analysis
Table Emcure Pharmaceuticals Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Biosimilar Drug Picture and Specifications of Emcure Pharmaceuticals
Table Biosimilar Drug Capacity (K Dose), Production (K Dose), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Emcure Pharmaceuticals 2011-2016
Figure Biosimilar Drug Capacity (K Dose), Production (K Dose) and Growth Rate of Emcure Pharmaceuticals 2011-2016
Figure Biosimilar Drug Production (K Dose) and United States Market Share of Emcure Pharmaceuticals 2011-2016
Table Emcure Pharmaceuticals Biosimilar Drug SWOT Analysis
Table Probiomed Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Biosimilar Drug Picture and Specifications of Probiomed
Table Biosimilar Drug Capacity (K Dose), Production (K Dose), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Probiomed 2011-2016
Figure Biosimilar Drug Capacity (K Dose), Production (K Dose) and Growth Rate of Probiomed 2011-2016
Figure Biosimilar Drug Production (K Dose) and United States Market Share of Probiomed 2011-2016
Table Probiomed Biosimilar Drug SWOT Analysis
Table Biosidus Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Biosimilar Drug Picture and Specifications of Biosidus
Table Biosimilar Drug Capacity (K Dose), Production (K Dose), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Biosidus 2011-2016
Figure Biosimilar Drug Capacity (K Dose), Production (K Dose) and Growth Rate of Biosidus 2011-2016
Figure Biosimilar Drug Production (K Dose) and United States Market Share of Biosidus 2011-2016
Table Biosidus Biosimilar Drug SWOT Analysis
Table 3SBio Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Biosimilar Drug Picture and Specifications of 3SBio
Table Biosimilar Drug Capacity (K Dose), Production (K Dose), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of 3SBio 2011-2016
Figure Biosimilar Drug Capacity (K Dose), Production (K Dose) and Growth Rate of 3SBio 2011-2016
Figure Biosimilar Drug Production (K Dose) and United States Market Share of 3SBio 2011-2016
Table 3SBio Biosimilar Drug SWOT Analysis
Table WOCKHARDT Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Biosimilar Drug Picture and Specifications of WOCKHARDT
Table Biosimilar Drug Capacity (K Dose), Production (K Dose), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of WOCKHARDT 2011-2016
Figure Biosimilar Drug Capacity (K Dose), Production (K Dose) and Growth Rate of WOCKHARDT 2011-2016
Figure Biosimilar Drug Production (K Dose) and United States Market Share of WOCKHARDT 2011-2016
Table WOCKHARDT Biosimilar Drug SWOT Analysis
Table Sun Pharmaceutical Industries Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Biosimilar Drug Picture and Specifications of Sun Pharmaceutical Industries
Table Biosimilar Drug Capacity (K Dose), Production (K Dose), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Sun Pharmaceutical Industries 2011-2016
Figure Biosimilar Drug Capacity (K Dose), Production (K Dose) and Growth Rate of Sun Pharmaceutical Industries 2011-2016
Figure Biosimilar Drug Production (K Dose) and United States Market Share of Sun Pharmaceutical Industries 2011-2016
Table Sun Pharmaceutical Industries Biosimilar Drug SWOT Analysis
Table Shanghai Fosun Pharmaceutical Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Biosimilar Drug Picture and Specifications of Shanghai Fosun Pharmaceutical
Table Biosimilar Drug Capacity (K Dose), Production (K Dose), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Shanghai Fosun Pharmaceutical 2011-2016
Figure Biosimilar Drug Capacity (K Dose), Production (K Dose) and Growth Rate of Shanghai Fosun Pharmaceutical 2011-2016
Figure Biosimilar Drug Production (K Dose) and United States Market Share of Shanghai Fosun Pharmaceutical 2011-2016
Table Shanghai Fosun Pharmaceutical Biosimilar Drug SWOT Analysis
Table Qilu Pharmaceutical Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Biosimilar Drug Picture and Specifications of Qilu Pharmaceutical
Table Biosimilar Drug Capacity (K Dose), Production (K Dose), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Qilu Pharmaceutical 2011-2016
Figure Biosimilar Drug Capacity (K Dose), Production (K Dose) and Growth Rate of Qilu Pharmaceutical 2011-2016
Figure Biosimilar Drug Production (K Dose) and United States Market Share of Qilu Pharmaceutical 2011-2016
Table Qilu Pharmaceutical Biosimilar Drug SWOT Analysis
Table Allergan Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Biosimilar Drug Picture and Specifications of Allergan
Table Biosimilar Drug Capacity (K Dose), Production (K Dose), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Allergan 2011-2016
Figure Biosimilar Drug Capacity (K Dose), Production (K Dose) and Growth Rate of Allergan 2011-2016
Figure Biosimilar Drug Production (K Dose) and United States Market Share of Allergan 2011-2016
Table Allergan Biosimilar Drug SWOT Analysis
Table Dongbao Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Biosimilar Drug Picture and Specifications of Dongbao
Table Biosimilar Drug Capacity (K Dose), Production (K Dose), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Dongbao 2011-2016
Figure Biosimilar Drug Capacity (K Dose), Production (K Dose) and Growth Rate of Dongbao 2011-2016
Figure Biosimilar Drug Production (K Dose) and United States Market Share of Dongbao 2011-2016
Table Dongbao Biosimilar Drug SWOT Analysis
Table Samsung Biologics Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Biosimilar Drug Picture and Specifications of Samsung Biologics
Table Biosimilar Drug Capacity (K Dose), Production (K Dose), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Samsung Biologics 2011-2016
Figure Biosimilar Drug Capacity (K Dose), Production (K Dose) and Growth Rate of Samsung Biologics 2011-2016
Figure Biosimilar Drug Production (K Dose) and United States Market Share of Samsung Biologics 2011-2016
Table Samsung Biologics Biosimilar Drug SWOT Analysis
Table Zydus Cadila. Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Biosimilar Drug Picture and Specifications of Zydus Cadila.
Table Biosimilar Drug Capacity (K Dose), Production (K Dose), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Zydus Cadila. 2011-2016
Figure Biosimilar Drug Capacity (K Dose), Production (K Dose) and Growth Rate of Zydus Cadila. 2011-2016
Figure Biosimilar Drug Production (K Dose) and United States Market Share of Zydus Cadila. 2011-2016
Table Zydus Cadila. Biosimilar Drug SWOT Analysis
Table Dong-A Pharmaceutical Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Biosimilar Drug Picture and Specifications of Dong-A Pharmaceutical
Table Biosimilar Drug Capacity (K Dose), Production (K Dose), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Dong-A Pharmaceutical 2011-2016
Figure Biosimilar Drug Capacity (K Dose), Production (K Dose) and Growth Rate of Dong-A Pharmaceutical 2011-2016
Figure Biosimilar Drug Production (K Dose) and United States Market Share of Dong-A Pharmaceutical 2011-2016
Table Dong-A Pharmaceutical Biosimilar Drug SWOT Analysis
Table Biosimilar Drug Price by Regions 2011-2016
Table Biosimilar Drug Price by Product Types 2011-2016
Table Biosimilar Drug Price by Companies 2011-2016
Table Biosimilar Drug Gross Margin by Companies 2011-2016
Table Price Comparison of Biosimilar Drug by Regions 2011-2016 (USD/Dose)
Table Price of Different Biosimilar Drug Product Types (USD/Dose)
Table Market Share of Different Biosimilar Drug Price Level
Table Gross Margin of Different Biosimilar Drug Applications
Table Marketing Channels Status of Biosimilar Drug
Table Traders or Distributors of Biosimilar Drug with Contact Information
Table Ex-work Price, Channel Price and End Buyer Price of Biosimilar Drug (USD/Dose) in 2015
Table United States Import, Export, and Trade of Biosimilar Drug (K Dose)
Figure United States Capacity (K Dose), Production (K Dose) and Growth Rate of Biosimilar Drug 2016-2021
Figure United States Capacity Utilization Rate of Biosimilar Drug 2016-2021
Table United States Biosimilar Drug Production by Type 2016-2021 (K Dose)
Table United States Biosimilar Drug Production Market Share by Type 2016-2021
Figure United States Production Market Share of Biosimilar Drug by Type in 2021
Figure United States Sales (K Dose) and Growth Rate of Biosimilar Drug 2016-2021
Figure United States Sales Revenue (Million USD) and Growth Rate of Biosimilar Drug 2016-2021
Figure United States Sales of Biosimilar Drug by Applications 2016-2021 (K Dose)
Table United States Production Market Share of Biosimilar Drug by Applications 2016-2021
Figure United States Production Market Share of Biosimilar Drug by Applications in 2021
Table United States Production, Import, Export and Consumption of Biosimilar Drug 2016-2021 (K Dose)
Table United States Production (K Dose), Price (USD/Dose), Cost (USD/Dose), Revenue (M USD) and Gross Margin of Biosimilar Drug 2016-2021
Table Major Raw Materials Suppliers of Biosimilar Drug with Contact Information
Table Manufacturing Equipment Suppliers of Biosimilar Drug with Contact Information
Table Major Players of Biosimilar Drug with Contact Information
Table Key Consumers of Biosimilar Drug with Contact Information
Table Supply Chain Relationship Analysis of Biosimilar Drug
Table New Project SWOT Analysis of Biosimilar Drug
Table New Project Investment Feasibility Analysis of Biosimilar Drug
Table Part of Interviewees Record List
...
Publisher Name : QYResearch

SIMILAR MARKET STUDIES

Please Select Format
Single User: US $ 3800
Enterprise User: US $ 7600

NEED MORE INFORMATION
Contact us
Call us +1-971-202-1575
--- or ---
help@bigmarketresearch.com
WHY BIG MARKET RESEARCH
With high quality and penned to perfection, Big Market Research is an exclusive online market to get best market research reports for your business needs and strategies. We recommend you to stop browsing as soon as you discover our website. This is because we firmly believe that once you reach here; all your business concerns will be addressed.

We have a huge collection of market research report from numerous filed which will provide you with all the necessary solution. We make sure that reports that we sell are true in context, have a quality that is unrivaled, fully integrated with equal spread of opinion. They will give you proper insights into different opportunities one may locate for their start-up pr expansion.

Let your qualms and concern be sidelined through our high end syndicated as well as customized reports.
Top